JPRN-UMIN000001048已完成2 期
The multicenter phase II study of opioid based pain control program for head and neck cancer patients recieving chemoradiotherapy - SCHN-A001
Study for establishment of prevention and therapy of oral complication induced by cancer treatment0 个研究点目标入组 110 人开始时间: 2008年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 women who are pregnant or breast feeding 2 with mental disorder 3 recieve the systemic therapy of steroid continuously 4 have the history of Miocardial infarction within 3 months 5 recieve the opioid therapy for cancer pain 6 with sever active co-mobidity (COPD, interstitial pneumonitis, angina pectoris and so on) 7 with severe infectious disease 8 do not agree with constructing PEG 9 with collagenosis
研究者
相似试验
进行中（未招募）
1 期
A randomized multicentre phase II trial with pazopanib and weekly paclitaxel vs weekly paclitaxel in platinum resistant or refractory ovarian cancer - MITO - 11platinum resistant or refractory ovarian cancerMedDRA version: 9.1Level: LLTClassification code 10033130EUCTR2009-016151-21-ITISTITUTO NAZIONALE PER LO STUDIO E LA CURA DEI TUMORI - FONDAZIONE G. PASCALE72
进行中（未招募）
1 期
An open label, multicenter, Phase I/II study of pazopanib in combination with paclitaxel in first line treatment of subjects with stage IIIBwet/IV non-small cell lung cancerPart I: Subjects with histologically or cytologically confirmed diagnosis of advanced solid tumours for which there is no standard therapy or for whom paclitaxel is standard therapy. Part II: Stage IIIB wet (with histologically- or cytologically-confirmed malignant pleural effusion) or Stage IV NSCLCMedDRA version: 9.1 Level: LLT Classification code 10029521 Term: Non-small cell lung cancer stage IIIBMedDRA version: 9.1 Level: LLT Classification code 10029522 Term: Non-small cell lung cancer stage IVEUCTR2009-010571-24-GBGlaxoSmithKline Research & Development Limited
已完成
2 期
A Prospective Phase II Multicenter Study for Prophylaxis of Acute Exacerbations of Interstitial Lung Disease after Lung Cancer ResectioInterstitial pneumonia Lung cancerJPRN-UMIN000008277Yokohama Consortium of Thoracic Surgeons70
终止
2 期
A Phase 2 Multi-Centre Study to Characterise the Pharmacodynamics of Vessel Dilator Peptide (VSDL) in Patients with Acute Decompensated Congestive Heart Failure to be assessed by effects on renal function.Acute Decompensated Congestive Heart FailureCardiovascular - Other cardiovascular diseasesACTRN12613001060730South Australian Health and Medical Research Institute65
已完成
2 期
Multicenter Phase II Clinical Study of the research on optimal assessments and treatment strategy of nilotinib in newly diagnosed chronic myelogenous leukemia patients in the chronic phase (CML-CP) based on early achievement of complete molecular response (CMR); N-roadChronic Myelogenous LeukemiaJPRN-UMIN000008565Cooperative study between Jikei University Kashiwa Hospital and Shimousa Hematology Study Group50